Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing

Géraldine Rios, View ORCID ProfileCaroline Lacoux, View ORCID ProfileVianney Leclercq, View ORCID ProfileAnna Diamant, View ORCID ProfileKévin Lebrigand, View ORCID ProfileAdèle Lazuka, View ORCID ProfileEmmanuel Soyeux, View ORCID ProfileSébastien Lacroix, Julien Fassy, View ORCID ProfileAurélie Couesnon, View ORCID ProfileRichard Thiery, View ORCID ProfileBernard Mari, View ORCID ProfileChristian Pradier, View ORCID ProfileRainer Waldmann, View ORCID ProfilePascal Barbry
doi: https://doi.org/10.1101/2021.07.09.21257475
Géraldine Rios
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Lacoux
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline Lacoux
Vianney Leclercq
2LBM BIOESTEREL, F06370 Mouans-Sartoux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vianney Leclercq
Anna Diamant
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Diamant
Kévin Lebrigand
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kévin Lebrigand
Adèle Lazuka
3Veolia, Scientific & Technological Expertise Department, Chemin de la Digue, F-78600 Maisons-Laffitte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adèle Lazuka
Emmanuel Soyeux
3Veolia, Scientific & Technological Expertise Department, Chemin de la Digue, F-78600 Maisons-Laffitte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmanuel Soyeux
Sébastien Lacroix
3Veolia, Scientific & Technological Expertise Department, Chemin de la Digue, F-78600 Maisons-Laffitte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sébastien Lacroix
Julien Fassy
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélie Couesnon
4ANSES, Sophia Antipolis Laboratory, F06902 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aurélie Couesnon
Richard Thiery
4ANSES, Sophia Antipolis Laboratory, F06902 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard Thiery
Bernard Mari
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernard Mari
Christian Pradier
5Université Côte d’Azur and Nice University Hospital, Public Health Department, F06560 Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Pradier
Rainer Waldmann
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rainer Waldmann
Pascal Barbry
1Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pascal Barbry
  • For correspondence: barbry{at}ipmc.cnrs.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Wastewater surveillance has been proposed as an epidemiological tool to define the prevalence and evolution of the SARS-CoV-2 epidemics. However, most implemented SARS-CoV-2 wastewater surveillance projects were relying on qPCR measurement of virus titers and did not address the mutational spectrum of SARS-CoV-2 circulating in the population.

Methods We have implemented a nanopore RNA sequencing monitoring system in the city of Nice (France, 550,000 inhabitants). Between October 2020 and March 2021, we monthly analyzed the SARS-CoV-2 variants in 113 wastewater samples collected in the main wastewater treatment plant and 20 neighborhoods.

Findings We initially detected the lineages predominant in Europe at the end of 2020 (B.1.160, B.1.177, B.1.367, B.1.474, and B.1.221). In January, a localized emergence of a variant (Spike:A522S) of the B.1.1.7 lineage occurred in one neighborhood. It rapidly spread and became dominant all over the city. Other variants of concern (B.1.351, P.1) were also detected in some neighborhoods, but at low frequency. Comparison with individual clinical samples collected during the same week showed that wastewater sequencing correctly identified the same lineages as those found in COVID-19 patients.

Interpretation Wastewater sequencing allowed to document the diversity of SARS-CoV-2 sequences within the different neighborhoods of the city of Nice. Our results illustrate how sequencing of sewage samples can be used to track pathogen sequence diversity in the current pandemics and in future infectious disease outbreaks.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

PB is supported by FRM (DEQ20180339158). The present work was possible thanks to the support of the National Infrastructure France Genomique (Commissariat aux Grands Investissements, ANR-10-INBS-09-03, ANR-10-INBS-09-02). BM is supported by Plan Cancer 2018 " ARN non-codants en cancerologie: du fondamental au translationnel " (Inserm number 18CN045) and Canceropole PACA.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The use of patient samples complied with French legislation. During the health emergency SARS-CoV-2 related patient data and laboratory results in France are recorded in the SARS-Cov2 Screening Information System SI-DEP ("Systeme Informations de DEPistage", French decree No. 2020-551 of May 12, 2020 ,Article 11 of Law No. 2020-546 of May 11, 2020 extending the state of health emergency). In the context of this law, patients can not object to the use of their SARS-CoV-2 related data for health surveys and epidemiological monitoring. Under this legislation, authorization of the use of patient data for research was granted unless patients actively express their opposition. A waiver of ethical approval was received from Mrs Elisabeth Huynh-Van, Data Protection Officer of the Nice University Hospital.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing Interests. The authors have read the journal’s policy and have the following competing interests: VL is employed by LBM Bioesterel, a Biogroup company. AL, ES and SL are employed by VEOLIA. There are no patents, products in development or marketed products associated with this research to declare.

Data Availability

All relevant data, custom software, R figures and analysis scripts are available on Github (https://github.com/ucagenomix/cagablea).

https://github.com/ucagenomix

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
Géraldine Rios, Caroline Lacoux, Vianney Leclercq, Anna Diamant, Kévin Lebrigand, Adèle Lazuka, Emmanuel Soyeux, Sébastien Lacroix, Julien Fassy, Aurélie Couesnon, Richard Thiery, Bernard Mari, Christian Pradier, Rainer Waldmann, Pascal Barbry
medRxiv 2021.07.09.21257475; doi: https://doi.org/10.1101/2021.07.09.21257475
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
Géraldine Rios, Caroline Lacoux, Vianney Leclercq, Anna Diamant, Kévin Lebrigand, Adèle Lazuka, Emmanuel Soyeux, Sébastien Lacroix, Julien Fassy, Aurélie Couesnon, Richard Thiery, Bernard Mari, Christian Pradier, Rainer Waldmann, Pascal Barbry
medRxiv 2021.07.09.21257475; doi: https://doi.org/10.1101/2021.07.09.21257475

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (754)
  • Anesthesia (221)
  • Cardiovascular Medicine (3287)
  • Dentistry and Oral Medicine (363)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13354)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5144)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3263)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14619)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4916)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2518)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4202)
  • Public and Global Health (7492)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (205)